Material below is adapted from the SfN Short Course Multiple Sclerosis: From Bench to Bedside and Back Again, by Steven L. Hauser, MD. Short Courses are daylong scientific trainings on emerging neuroscience topics and research techniques held the day before SfN’s annual meeting.
The connection between the type of immune cells called B-cells and multiple sclerosis (MS) was confirmed after unblinding a phase II clinical trial in 2006. The story of the challenges and successes that clinicians and researchers have faced in studying this connection reveals that coupling laboratory and clinical research can improve the efficacy of translational medicine.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
